Connect with us
Cronos will have the option to purchase up to 70% of GrowCo’s expanded production. Toronto-based Cronos Group Inc. (NASDAQ: CRON) plans to significantly expand its cultivation...
MediPharm said the deal will bring immediate revenue, as well as open global opportunities. MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) entered into a licensing agreement...
With the legislative session over for spring in Illinois, cannabis/hemp industry stakeholders across the state are regrouping and making plans for a veto session in the...
A New York City-specific fund for financially troubled marijuana companies is slated to begin awarding loans to businesses as soon as this summer. The Cannabis NYC...
Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) has signed a letter of intent to buy MedBright AI Investments Inc. in an all-stock deal. In addition to...
iAnthus has a New York adult-use license, but hasn’t paid the fee. Green Market Report Executive Editor Debra Borchardt caught up with iAnthus CEO Ritchie Proud...
Among mainstream industries, public companies will sometimes repurchase shares they issued in the past, ostensibly to increase the value of the remaining shares held by investors,...
The Massachusetts Cannabis Control Commission is in such bad shape that lawmakers need to appoint a receiver to take the reins at the regulatory agency, the...
News from: Massachusetts, US Congress, Klutch Cannabis, and more. The Daily Hit is a recap of the top financial news stories for Wednesday, June 19, 2024....
Privately owned psychedelic therapy company Mindbloom announced the positive findings of the largest peer-reviewed study regarding ketamine therapy and psychedelic medicine. The study, published in the Journal of...
